No Data
No Data
Luyan Pharma Co.,Ltd. (SZSE:002788) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
It looks like Luyan Pharma Co.,Ltd. (SZSE:002788) is about to go ex-dividend in the next three days. The ex-dividend date is usually set to be one business day before the record date which is the cut
Luyan Pharma (002788.SZ) 2023 annual equity distribution: 3 yuan per 10 shares, record date on July 3.
Luyan Pharma (002788.SZ) released an announcement, the company's annual equity distribution plan for 2023 is: based on the current ...
Luyan Pharmaceutical (002788.SZ): Net profit of 83.7764 million yuan in the first quarter increased 4.90% year-on-year
Gelonghui, April 15, 丨 Luyan Pharmaceutical (002788.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 5.136 billion yuan, up 6.08% year on year; net profit attributable to shareholders of listed companies was 83.7764 million yuan, up 4.90% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 82.7597 million yuan, up 5.21% year on year; basic earnings per share were 0.22 yuan.
Earnings Working Against Luyan Pharma Co.,Ltd.'s (SZSE:002788) Share Price Following 29% Dive
The Luyan Pharma Co.,Ltd. (SZSE:002788) share price has fared very poorly over the last month, falling by a substantial 29%. The drop over the last 30 days has capped off a tough year for sharehold
Luyan Pharmaceutical (002788.SZ) received concerted action from controlling shareholder Wang Jun to increase holdings by 372,000 shares
Zhitong Finance App News, Luyan Pharmaceutical (002788.SZ) issued an announcement. On February 2, 2024, the company received a notice from Ms. Wang Jun, the controlling shareholder of Xiamen Medicon Technology Co., Ltd. (“Medican”). Based on confidence in the company's future continuous and stable development and reasonable judgment on the company's current investment value, Ms. Wang Jun increased her shareholding by 372,000 shares through the Shenzhen Stock Exchange stock trading system on February 2, 2024 through centralized bidding.
Luyan Pharmaceutical (002788.SZ) has not carried out research on the practical application of blockchain technology in the field of pharmaceutical product distribution
Gelonghui, Feb. 4 | Luyan Pharmaceutical (002788.SZ) said on the investor interactive platform that the company is concerned about the development and application of new technologies and continues to use them to enhance the company's business. However, research on the actual application of blockchain technology in the field of pharmaceutical product distribution has not yet been carried out.
No Data